LEMAITRE VASCULAR, INC. Proceeds from Sale of Buildings
LEMAITRE VASCULAR, INC. (LMAT) reported Proceeds from Sale of Buildings of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfBuildings · last filed 2025-02-28
- LEMAITRE VASCULAR, INC. proceeds from sale of buildings for the quarter ending 2021-12-31 was $0.00.
- LEMAITRE VASCULAR, INC. proceeds from sale of buildings for the quarter ending 2020-12-31 was $0.00.
- LEMAITRE VASCULAR, INC. proceeds from sale of buildings for the quarter ending 2019-12-31 was $0.00.
- LEMAITRE VASCULAR, INC. proceeds from sale of buildings for fiscal 2024 was $0.00.
- LEMAITRE VASCULAR, INC. proceeds from sale of buildings for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- LEMAITRE VASCULAR, INC. proceeds from sale of buildings for fiscal 2022 was $858.00K.
- LEMAITRE VASCULAR, INC. proceeds from sale of buildings for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
| Period end | Proceeds from Sale of Buildings 3 month | Proceeds from Sale of Buildings 9 month | Proceeds from Sale of Buildings 12 month |
|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-28 | ||
| 2023-12-31 | $0.00 10-K · filed 2025-02-28 | ||
| 2022-12-31 | $858.00K 10-K · filed 2025-02-28 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $0.00 10-K · filed 2024-02-29 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-04 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $2.02M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $2.02M 10-Q · filed 2021-11-04 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 | |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-06 | ||
| 2018-12-31 | $0.00 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |